Komori
Share Issuance and Disposal4263SUSMED,Inc.Information and Communications, Services and Others

Notice Regarding the Issuance of New Shares as Restricted Stock-Based Compensation

The company resolved to newly issue 73,200 common shares to 4 directors as restricted stock compensation. The issue price is ¥443 per share, and the payment date is 19 October 2026.

Worth reading
48Recurring
Scored from 4 of 5 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
73200
Shares
Wording
Definitive
How definitive the wording is.

Details of issuance or disposal

Issuance of new shares as restricted stock compensation

Who receives how much73,200Shares

73,200 common shares (new shares)

4 directors (excluding directors who are Audit and Supervisory Committee members), 73,200 shares

The lower thin line represents the existing number of shares to which these shares will be added.

¥443 per share
Total issue value

¥32,427,600

Total Stock-Based Compensation
Total monetary remuneration receivables of ¥443 (for this issuance). The remuneration framework is capped at ¥50 million per year, including up to ¥5 million for outside directors.
Conditions on transfer restrictions

Restricted stock is stock awarded as compensation that cannot be sold during a specified period, with the restrictions lifted once the applicable conditions are met.

Transfer restriction period
From 19 October 2026 to 18 October 2029 (3 years)
Conditions for lifting transfer restrictions
The transfer restrictions will be lifted on all of the allocated shares held at the end of the restriction period, provided that the recipient has continuously remained a director of the company throughout the restriction period. If the recipient retires for a legitimate reason, the number of shares to be released and the timing of release will be reasonably adjusted. Special provisions apply in the event of a reorganization or similar transaction.
Reason for acquisition without consideration
If the recipient retires as a director before the end of the restriction period, except where the Board of Directors recognizes a legitimate reason. Also, if any shares remain subject to transfer restrictions at the end of the restriction period. The same applies if any shares remain subject to transfer restrictions as of the business day preceding the effective date of a reorganization or similar transaction.
Categories and Number of Persons Covered
4 of the company's directors (excluding directors who are Audit and Supervisory Committee members), 73,200 shares
Intended allottee's holding policy
During the restriction period, the shares may not be transferred to a third party, pledged, made subject to a transfer security interest, gifted inter vivos, bequeathed or otherwise disposed of in any way. The shares will be held and maintained in a designated account until the transfer restrictions are lifted.
Payment date
19 October 2026
Basis for determining the amount to be paid
The closing price of the company's common shares on the Tokyo Stock Exchange on 28 September 2026 was ¥443. No discount or premium.
Details of issuance or disposal
ItemDetails
Type of issuance or disposalIssuance of new shares as restricted stock compensation
Number of shares to be issued or disposed of73,200 common shares (new shares)
Issue price and disposal price¥443 per share
Total issue value¥32,427,600
Payment date19 October 2026
Intended allottee4 directors (excluding directors who are Audit and Supervisory Committee members), 73,200 shares
Intended allottee's holding policyDuring the restriction period, the shares may not be transferred to a third party, pledged, made subject to a transfer security interest, gifted inter vivos, bequeathed or otherwise disposed of in any way. The shares will be held and maintained in a designated account until the transfer restrictions are lifted.
Basis for determining the amount to be paidThe closing price of the company's common shares on the Tokyo Stock Exchange on 28 September 2026 was ¥443. No discount or premium.
Transfer restriction periodFrom 19 October 2026 to 18 October 2029 (3 years)
Conditions for lifting transfer restrictionsThe transfer restrictions will be lifted on all of the allocated shares held at the end of the restriction period, provided that the recipient has continuously remained a director of the company throughout the restriction period. If the recipient retires for a legitimate reason, the number of shares to be released and the timing of release will be reasonably adjusted. Special provisions apply in the event of a reorganization or similar transaction.
Reason for acquisition without considerationIf the recipient retires as a director before the end of the restriction period, except where the Board of Directors recognizes a legitimate reason. Also, if any shares remain subject to transfer restrictions at the end of the restriction period. The same applies if any shares remain subject to transfer restrictions as of the business day preceding the effective date of a reorganization or similar transaction.
Categories and Number of Persons Covered4 of the company's directors (excluding directors who are Audit and Supervisory Committee members), 73,200 shares
Total Stock-Based CompensationTotal monetary remuneration receivables of ¥443 (for this issuance). The remuneration framework is capped at ¥50 million per year, including up to ¥5 million for outside directors.
Items this document does not state (15)
Amount of funds to be raisedEstimated issuance expensesSpecific use of fundsDilution RateTotal number of issued sharesExercise priceExercise periodNumber of Stock Acquisition RightsUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMost recent equity financingMajor shareholders after the offeringImpact on Business Performance

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

To align the directors' interests with shareholders by sharing the benefits and risks of share price fluctuations and to enhance their motivation to contribute to an increase in the share price and corporate value.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding the Issuance of New Shares as Restricted Stock-Based Compensation | SUSMED,Inc. (4263) timely disclosure | Komori